High-Content Phenotypic Profiling in Esophageal Adenocarcinoma Identifies Selectively Active Pharmacological Classes of Drugs for Repurposing and Chemical Starting Points for Novel Drug Discovery. (2020)
Attributed to:
UKRMP Hub: The Engineered Cell Environment.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1177/2472555220917115
PubMed Identifier: 32441181
Publication URI: http://europepmc.org/abstract/MED/32441181
Type: Journal Article/Review
Volume: 25
Parent Publication: SLAS discovery : advancing life sciences R & D
Issue: 7
ISSN: 2472-5552